Intelomed, Inc. CEO Jill Schiaparelli to Guest Host National Talk Radio Show at MD&M Conference in Philadelphia — iHeart Radio’s HealthTechTalk
MD&M Philadelphia Conference October 7th & 8th, Sponsored by UBM Canon MedTech World
WEXFORD, PA, Oct 6, 2015 – InteloMed, Inc., a leading developer of non-invasive cardiovascular monitoring systems, announced today that CEO Jill Schiaparelli will guest host a special edition of HealthTechTalk Live Radio Show at the UBM MedTech World Medical Design and Manufacturing (MD&M) conference in Philadelphia on October 7th and 8th, 2015.
Live on location from MD&M Philadelphia, the four-state region’s largest medtech event, HealthTechTalk Live will interview some of the most high-profile, innovative industry and academic leaders presenting at the conference.
Serving a broad community of medtech professionals, MD&M Philadelphia delves into the latest challenges and opportunities that are impacting the industry. A multi-track conference program explores design innovations, 3D printing, new materials, packaging design and more.
About UBM Canon
UBM Canon is the leading B-to-B event producer, publisher, and digital media company for the world’s $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the advanced manufacturing market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. UBM Canon is part of UBM plc (UBM.L), a global provider of media and information services for professional B-to-B communities and markets.
About HealthTechTalk Live Radio Show
HealthTechTalk Live Show broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm every Saturday. Guest host Jill Schiaparelli interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTechTalk Live, http://www.healthtechtalk.com/.
InteloMed is redefining the standard of care in intelligent cardiovascular monitoring in hospitals and health care facilities through its non-invasive CVInsight™ Platform. The CVInsight™ Platform provides real-time insights on the stress level of the cardiovascular system to inform clinical decisions which, as part of a well-managed care plan, may lead to earlier detection of cardiovascular decline, earlier intervention, decreased hospitalization and improved patient outcomes. The CVInsight™ Platform has functionality in hospital and outpatient settings and has clinical applications in multiple areas including hemodialysis, heart failure, and the surgical continuum. InteloMed is headquartered in Wexford, PA. For more information, visit us at www.InteloMed.com.
Safe Harbor Statement
Certain statements in this release are “forward-looking” and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage qualified employees, the acceptance of new products by doctors and hospitals, changes in the regulatory environment and healthcare legislation, the need to keep pace with technological changes, our dependence on third party manufacturers to produce components of our technology platform on time and to our specifications, and the successful implementation of our commercial strategies.
PR & Media Contact:
Matt Bird, CEO
C: +1 (646) 401-4499